English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/58724
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Short-Term Efficacy of Intravitreal Dobesilate in Central Serous Chorioretinopathy.

AuthorsCuevas, Pedro; Outeiriño, Luis A.; Azanza, Carlos; Angulo, Javier; Giménez-Gallego, Guillermo
Issue Date12-Jul-2012
PublisherBioMed Central
CitationEuropean Journal of Medical Research. 17(1):22 (2012)
AbstractAbstract Purpose To report the anatomic and functional outcome of intravitreal dobesilate to treat recurrent central serous chorioretinopathy (CSC). Methods This is an interventional case report in which dobesilate was intravitreally injected in a case of recurrent CSC. Main measures included fundoscopy, Snellen visual acuity (VA) testing, fluorescein angiography and optical coherence tomography (OCT). Results We present anatomical and functional evidences, obtained as early as eleven days after the treatment, of the efficacy of intravitreal dobesilate, in the treatment of chronic CSC condition. The effect after intravitreal dobesilate injection for CSC might be related to the normalization of retinal architecture. Conclusions Intravitreal dobesilate may be an effective treatment option for recurrent CSC.
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
2047-783X-17-22.xml44,85 kBXMLView/Open
2047-783X-17-22.pdf237,63 kBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.